The Issue

Slow Biosimilar Adoption is Costing the U.S. Billions

How much savings have patients & taxpayers lost since 2018 without biosimilars?

Patients and Taxpayers Have Lost Billions
Not Using Biosimilars

Year-to-Date Lost Savings*
2018 – 2021

$23,848,848,450

Out-of-Pocket Lost Savings*
2021

$260,768,669

Year-to-Date Lost Savings*
2021

$9,542,856,989